The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300

EMBO Journal

Volumn 18, Issue 18, 1999, Pages 5061-5072

  Patel, Daksha ^a   Huang, Shih Min ^a   Baglia, Laurel A ^a   McCance, Dennis J ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

CBP; E6 protein; Human papillomavirus; p300; Transcription co activators

Indexed keywords

CELL PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P53; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; GENE MUTATION; GENETIC TRANSCRIPTION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; WART VIRUS;

ANIMALS; BINDING SITES; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE; GENES, P53; HUMANS; MUTATION; NF-KAPPA B; NUCLEAR PROTEINS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PEPTIDE MAPPING; PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; REPRESSOR PROTEINS; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS;

ANIMALIA; DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; PAPOVAVIRIDAE;

EID: 0033568491     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/18.18.5061     Document Type: Article

References (62)

1. Ait-Si-Ali, S. et al. (1998) Histone deacetylase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A. Nature, 396, 184-186.
2. Angel, P. and Karin, M. (1991) The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta, 1072, 129-157.
3. Arany, Z., Newsome, D., Oldread, E., Livingston, D.M. and Eckner, R. (1995) A family of transcriptional adaptor proteins targeted by the E1A oncoprotein. Nature, 374, 81-84.
4. Arias, J., Alberts, A.S., Brindle, P., Claret, F.X., Smeal, T., Karin, M., Feramisco, J. and Montminy, M. (1994) Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature, 370, 226-229.
5. Avantaggiati, M.L., Ogryzko, V., Gardner, K., Giordano, A., Levine, A.S. and Kelly, K. (1997) Recruitment of p300/CBP in p53-dependent signal pathways. Cell, 89, 1175-1184.
6. Baldwin, A.S. (1996) The NF-κB and Iκ-B proteins: New discoveries and insights. Annu. Rev. Immunol., 14, 649-681.
7. Bannister, A.J. and Kouzarides, T. (1995) CBP-induced stimulation of c-Fos activity is abrogated by E1A. EMBO J., 14, 4758-4762.
8. Bannister, A.J. and Kouzarides, T. (1996) The CBP co-activator is a histone acetyltransferase. Nature, 384, 641-643.
9. Bontkes, H.J., Walboomers, J.M., Meijer, C.J., Helmerhorst, T.J. and Stern, P.L. (1998) Specific HLA class I down-regulation is an early event in cervical dysplasia associated with clinical progression. Lancet, 351, 187-188.
10. Chakravarti, D., Ogryzko, V., Kao, H.-Y., Nash, A., Chen, H., Nakatani, Y. and Evans, R.M. (1999) A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity. Cell, 96, 393-403.
11. Chrivia, J.C., Kwok, R.P., Lamb, N., Hagiwara, M., Montminy, M.R. and Goodman, R.H. (1993) Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature. 365, 855-859.
12. Cromme, F.V., Airey, J., Heemels, M.T., Ploegh, H.L., Keating, P.J., Stern, P.L., Meijer, C.J. and Walboomers, J.M. (1994a) Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas. J. Exp. Med., 179, 335-340.
13. Cromme, F.V., Van Bommel, P.F., Walboomers, J.M., Gallee, M.P., Stern, P.L., Kenemans, P., Helmerhorst, T.J., Stukart, M.J. and Meijer, C.J. (1994b) Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours. Br. J. Cancer, 69, 1176-1181.
14. Crook, T., Tidy, J.A. and Vousden, K.H. (1991) Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell, 67, 547-556.
15. Dai, P., Akimaru, H., Tanaka, Y., Hou, D.X., Yasukawa, T., Kanei-Ishii, C., Takahashi, T. and Ishii, S. (1996) CBP as a transcriptional coactivator of c-Myb. Genes Dev., 10, 528-540.
16. Dalai, S., Gao, Q., Androphy, E.J. and Band, V. (1996) Mutational analysis of human papillomavirus type 16 E6 demonstrates that p53 degradation is necessary for immortalization of mammary epithelial cells. J. Virol., 70, 683-688.
17. Eckner, R., Ewen, M.E., Newsome, D., Gerdes, M., DeCaprio, J.A., Lawrence, J.B. and Livingston, D.M. (1994) Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev., 8, 869-884.
18. Eckner, R., Ludlow, J.W., Lill, N.L., Oldread, E., Arany, Z., Modjtahedi, N., DeCaprio, J.A., Livingston, D.M. and Morgan, J.A. (1996a) Association of p300 and CBP with simian virus 40 large T antigen. Mol. Cell. Biol., 16, 3454-3464.
19. Eckner, R., Yao, T.P., Oldread, E. and Livingston, D.M. (1996b) Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation. Genes Dev., 10, 2478-2490.
20. Foster, S.A., Demers, G.W., Etscheid, B.G. and Galloway, D.A. (1994) The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest. J. Virol., 68, 5698-5705.
21. Funk, J.O., Waga, S., Harry, J.B., Espling, E., Stillman, B. and Galloway, D.A. (1997) Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein. Genes Dev., 11, 2090-2100.
22. Giles, R.H., Peters, D.J. and Breuning, M.H. (1998) Conjunction dysfunction: CBP/p300 in human disease. Trends Genet., 14, 178-183.
23. Grossman, S.R., Perez, M., Kung, A.L., Joseph, M., Mansur, C., Xiao, Z.X., Kumar, S., Howley, P. and Livingston, D.M. (1998) p300/MDM2 complexes participate in MDM2-mediated p53 degradation. Mol. Cell, 2, 405-415.
24. Gu, W., Shi, X.-L. and Roeder, R.G. (1997) Synergistic activation of transcription by CBP and p53. Nature, 387, 819-822.
25. Hamamori, Y., Sartorelli, V., Ogryzko, V., Puri, P.L., Wu, H.-Y., Wang, J.Y.J., Nakatani, Y. and Kedes, L. (1999) Regulation of histone acetyltransferases p300 and PCAF by the bHLH protein Twist and adenoviral oncoprotein E1A. Cell, 96, 405-413.
26. Hu, Y., Baud, V., Delhase, M., Zhang, P., Deerinck, T., Ellisman, M., Johnson, R. and Karin, M. (1999) Abnormal morphogenesis but intact IKK activation in mice lacking the IKK-α subunit of IκB. Science, 284, 316-320.
27. Huibregtse, J.M., Scheffner, M. and Howley, P.M. (1991) A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J., 10, 4129-4135.
28. Jones, D.L., Alani, R.M. and Munger, K. (1997) The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2. Genes Dev., 11, 2101-2111.
29. Kamei, Y. et al. (1996) A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell, 85, 403-414.
30. Kawasaki, H., Eckner, R., Yao, T.P., Taira, K., Chiu, R., Livingston, D.M. and Yokoyama, K.K. (1998) Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation. Nature, 393, 284-289.
31. Keating, P.J., Cromme, F.V., Duggan-Keen, M., Snijders, P.J., Walboomers, J.M., Hunter, R.D., Dyer, P.A. and Stern, P.L. (1995) Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression. Br. J. Cancer, 72, 405-411.
32. Korzus, E., Torchia, J., Rose, D.W., Xu, L., Kurokawa, R., McInerney, E.M., Mullen, T.M., Glass, C.K. and Rosenfeld, M.G. (1998) Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science, 279, 703-707.
33. Kurokawa, R., Kalafus, D., Ogliastro, M.H., Kioussi, C., Xu, L., Torchia, J., Rosenfeld, M.G. and Glass, C.K. (1998) Differential use of CREB binding protein-coactivator complexes. Science, 279, 700-703.
34. Kwok, R.P., Lundblad, J.R., Chrivia, J.C., Richards, J.P., Bachinger, H.P., Brennan, R.G., Roberts, S.G., Green, M.R. and Goodman, R.H. (1994) Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature, 370, 223-226.
35. Kwok, R.P., Laurance, M.E., Lundblad, J.R., Goldman, P.S., Shih, H., Connor, L.M., Marriott, S.J. and Goodman, R.H. (1996) Control of cAMP-regulated enhancers by the viral transactivator Tax through CREB and the co-activator CBP. Nature, 380, 642-646.
36. Lee, J.S., See, R.H., Deng, T. and Shi, Y. (1996) Adenovirus E1A downregulates cJun-and JunB-mediated transcription by targeting their coactivator p300. Mol. Cell. Biol., 16, 4312-4326.
37. Lundblad, J.R., Kwok, R.P., Laurance, M.E., Harter, M.L. and Goodman, R.H. (1995) Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP. Nature, 374, 85-88.
38. McCance, D.J. (1998) Human papillomaviruses and cervical cancer. J. Med. Microbiol., 47, 371-373.
39. Meyers, G. and Androphy, E. (1995) The E6 protein. Human papillomaviruses: Los Alamos Data Base, III-47-III-57.
40. Nakajima, J., Uchida, C., Anderson, S.F, Lee, C.G., Hurwitz, J., Parvin, J.D. and Montminy, M. (1997a) RNA helicase A mediates association of CBP with RNA polymerase II. Cell, 90, 1107-1112.
41. Nakajima, T., Uchida, C., Anderson, S.F., Parvin, J.D. and Montminy, M. (1997b) Analysis of a cAMP-responsive activator reveals a two-component mechanism for transcriptional induction via signal-dependent factors. Genes Dev., 11, 738-747.
42. Oelgeschlager, M., Janknecht, R., Krieg, J., Schreek, S. and Luscher, B. (1996) Interaction of the co-activator CBP with Myb proteins: effects on Myb-specific transactivation and on the cooperativity with NF-M. EMBO J., 15, 2771-2780.
43. Ogryzko, V.V., Schiltz, R.L., Russanova, V., Howard, B.H. and Nakatani, Y. (1996) The transcriptional coactivators p300 and CBP are histone deacetylases. Cell, 87, 953-959.
44. Onate, S.A., Tsai, S.Y., Tsai, M.J. and O'Malley, B.W. (1995) Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science, 270, 1354-1357.
45. Puri, P.L., Avantaggiati, M.L., Balsano, C., Sang, N., Graessmann, A., Giordano, A. and Levrero, M. (1997) p300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription. EMBO J., 16, 369-383.
46. Scheffner, M., Werness, B.A., Huibregtse, J.M., Levine, A.J. and Howley, P.M. (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell, 63, 1129-1136.
47. Scheffner, M., Huibregtse, J.M., Vierstra, R.D. and Howley, P.M. (1993) The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell, 75, 495-505.
48. Scheffner, M., Huibregtse, J.M. and Howley, P.M. (1994) Identification of a human ubiquitin-conjugating enzyme that mediates the E6-AP-dependent ubiquitination of p53. Proc. Natl Acad. Sci. USA, 91, 8797-8801.
49. Sherman, L. and Schlegel, R. (1996) Serum-and calcium-induced differentiation of human keratinocytes is inhibited by the E6 oncoprotein of human papillomavirus type 16. J. Virol., 70, 3269-3279.
50. Sherman, L., Jackman, A., Itzhaki, H., Stoppler, M.C., Koval, D. and Schlegel, R. (1997) Inhibition of serum-and calcium-induced differentiation of human keratinocytes by HPV16 E6 oncoprotein: role of p53 inactivation. Virology, 237, 296-306.
51. Shikama, N., Lyon, J. and La Thangue, N.B. (1997) The p300/CBP family: integrating signals with transcription factors and chromatin. Trends Cell Biol., 7, 230-236.
52. Suzuki, T., Fujisawa, J.I., Toita, M. and Yoshida, M. (1993) The transactivator tax of human T-cell leukemia virus type-1 (HTLV-1) interacts with cAMP-responsive element (CRE) binding and the CRE modulator proteins that bind to the 21-base-pair enhancer of HTLV-1. Proc. Natl Acad. Sci. USA, 90, 610-614.
53. Takeda, K. et al. (1999) Limb and skin abnormalities in mice lacking IIKα. Science, 284, 313-316.
54. Tay, S.K., Jenkins, D., Maddox, P., Campion, M. and Singer, A. (1987a) Subpopulations of Langerhans' cells in cervical neoplasia. Br. J. Obstet. Gynaecol., 94, 10-15.
55. Tay, S.K., Jenkins, D., Maddox, P., Hogg, N. and Singer, A. (1987b) Tissue macrophage response in human papillomavirus infection and cervical intraepithelial neoplasia. Br. J. Obstet. Gynaecol., 94, 1094-1097.
56. Tay, S.K., Jenkins, D., Maddox, P. and Singer, A. (1987c) Lymphocyte phenotypes in cervical intraepithelial neoplasia and human papillomavirus infection. Br. J. Obstet. Gynaecol., 94, 16-21.
57. Tay, S.K., Jenkins, D. and Singer, A. (1987d) Natural killer cells in cervical intraepithelial neoplasia and human papillomavirus infection. Br. J. Obstet. Gynaecol., 94, 901-906.
58. Tomic-Canic, M., Komine, M., Freedberg, I.M. and Blumenberg, M. (1998) Epidermal signal transduction and transcription factor activation in activated keratinocytes. J. Dermatol. Sci., 17, 167-181.
59. Torchia, J., Rose, D.W., Inostroza, J., Kamei, Y., Westin, S., Glass, C.K. and Rosenfeld, M.G. (1997) The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature, 387, 677-684.
60. Yang, X.J., Ogryzko, V.V., Nishikawa, J., Howard, B.H. and Nakatani, Y. (1996) A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature, 382, 319-324.
61. Yuan, W., Condorelli, G., Caruso, M., Felsani, A. and Giordano, A. (1996) Human p300 protein is a coactivator for the transcription factor MyoD. J. Biol. Chem., 271, 9009-9013.
62. Zimmermann, H., Degenkolbe, R., Bernard, H.-U. and O'Connor, M.J. (1999) The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 by targeting the transcriptional coactivator CBP/p300. J. Virol., 73, 6209-6219.